The latter is strongly related to atherosclerosis, which is both an inflammatory disease involving NLRP3 activation and a vascular disease that may promote AD development by chronic hypoperfusion and the stiffening of arterial walls in the brain [80]. The gene discussed is NLRP3; the disease is atherosclerosis.